DOCS logo

Doximity Inc. DOCS

UnknownUnknownN/AπŸ“… Scored March 14, 2026
Price at analysis: $24.18
Crucible Score
74.5
B+
Quality Γ— Value Composite
KQI β€” Quality
76.8
B+
Fundamental Quality Index
KVI β€” Value
71.6
B
Valuation Attractiveness Index
Crucible Verdict β€” DOCS

Doximity Inc. (DOCS) presents a high-quality but narrowly focused business, with exceptional financial metrics and strong competitive moats offset by poor diversification and modest market position. The stock trades at a 25% discount to fair value despite a 97% earnings beat rate, suggesting the market remains concerned about DOCS' ability to expand beyond its core physician networking niche. Growth sustainability hinges on successful platform diversification.

β€” Kal, Kaladin Capital Intelligence

β—† KQI Quality Dimensions

Financial Quality
91.3
Growth Profile
80.6
Moat Durability
88.5
Management Effectiveness⚠
71.9
Diversification & Resilience⚠
18.0
Market Position
48.0
Weakest dimension: Diversification & Resilience (18.0)

β—† KVI Value Dimensions

DCF Margin of Safety
68.5
FCF Yield & Cash Returns
75.3
Relative Valuation
65.8
Growth-Adjusted Value
70.8
Historical Valuation
86.5
Macro Context
66.8

β—† DCF Valuation Scenarios

Bear Case
$18.52
Base Case
$30.14
Bull Case
$46.89
Price at Analysis
$24.18
ScenarioFair ValueRev CAGR (5yr)Terminal MarginWACC
πŸ”΄ Bear$18.528.0%32.0%12.3%
🟒 Base$30.1412.0%37.0%11.8%
🟒 Bull$46.8916.0%42.0%11.3%
Key Assumptions: WACC derived from CAPM using 4.39% risk-free rate, 1.44 beta, and 5.5% ERP yielding ~12.3% cost of equity; minimal debt makes WACC approximately equal to cost of equity with slight scenario adjustments. Revenue growth anchored to 5-year CAGR of ~29% but decelerating materially given maturing platform dynamics; operating margins reflect historical range of 26-40% with bear assuming competitive pressure and bull assuming continued operating leverage. Capex intensity remains very low at ~1.2% of revenue consistent with asset-light software model, and tax rate normalized to ~16% reflecting historical effective rates excluding the anomalous negative year.

β—† Financial Snapshot

Profitability

Gross Margin89.7%
Operating Margin37.4%
Net Margin37.5%
ROIC19.1%
ROE24.4%

Balance Sheet

Balance SheetD/E: 0.01*, CR: 6.63* (* = TTM)
Cash ConversionFCF/EPS: 1.30x
Capital IntensityCapex/Rev: 1.1%
Altman Z-Score17.83 (Safe)
Piotroski F-Score5/9 (Mixed)

Growth

Revenue CAGR28.9% CAGR
Earnings CAGR45.2% CAGR
Growth ConsistencyCV: 0.62
Segment Breadth2/2 growing (100%)
Quarterly TrendRevβ†’+17%, Margin↓, WC↓, Exp↓
Earnings CredibilityConsistent Beater

β—† Analyst Consensus & Leadership

Leadership & Governance

CEO Ownership31.3%
Compensation97% performance-based
Insider ActivitySelling
Capital AllocationROIC 19.1% vs WACC 12.4%
Earnings Beat Rate97% (21/22)

β—† Related Companies in Our Universe

Other Unknown companies scored by the Crucible:

Analysis conducted March 14, 2026 based on most recent SEC filings. Updated quarterly, after new SEC filings.

Point-in-time fundamental analysis. Not investment advice. Scores reflect company quality and valuation at time of analysis and may not reflect current market conditions.

Β© 2026 Kaladin Capital Intelligence β€” Conviction Through Scrutiny